Tyrosine Kinase/Adaptors
Tyrosine kinase and adaptor inhibitors are compounds that target tyrosine kinases and their associated adaptor proteins, which play pivotal roles in cell signaling, growth, and differentiation. These inhibitors are essential tools in cancer research, as many tyrosine kinases are involved in the signaling pathways that drive tumor growth and metastasis. By inhibiting tyrosine kinases, these compounds can block critical signaling cascades, offering potential therapeutic strategies for various cancers and other diseases involving abnormal cell signaling. At CymitQuimica, we provide a comprehensive range of high-quality tyrosine kinase and adaptor inhibitors to support your research in oncology, molecular biology, and targeted therapy development.
Read more
Subcategories of "Tyrosine Kinase/Adaptors"
ALK
CSF-1R
EGFR
Ephrin Receptor
FLT
Fibroblast Growth Factor Receptor (FGFR)
HER
Hck
IGF-1R
PDGFR
PYK2
Src
TAM Receptor
Tie-2
Trk receptor
Tyrosine Kinases
VEGFR
c-Fms
c-Kit
c-Met/HGFR
c-RET
Show 13 more subcategories
Products of "Tyrosine Kinase/Adaptors"
R916562
CAS:1037798-41-6
R916562 is an orally active and selective Axl/VEGF-R2 inhibitor with IC50s of 136 nM and …
Formula:
C26H30ClN9S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
536.09
Ref: TM-T12650
| 25mg | 1,410.00 € | ||
| 50mg | 1,852.00 € | ||
| 100mg | 2,338.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Glesatinib hydrochloride
CAS:1123838-51-6
Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET/SMO.
Formula:
C31H28ClF2N5O3S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
656.16
Ref: TM-T15383
| 25mg | 885.00 € | ||
| 50mg | 1,160.00 € | ||
| 100mg | 1,861.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
BMS-605541
CAS:639858-32-5
BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase …
Formula:
C19H17F2N5OS
Purity:
98.07%
Color and Shape:
Solid
Molecular weight:
401.43
Ref: TM-T26852
| 5mg | 49.00 € | ||
| 10mg | 79.00 € | ||
| 25mg | 152.00 € | ||
| 50mg | 239.00 € | ||
| 100mg | 353.00 € | ||
| 1mL*10mM (DMSO) | 61.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
(±)-Zanubrutinib
CAS:1633350-06-7
(±)-Zanubrutinib ((±)-BGB-3111) is a potent and orally available Bruton's tyrosine kinase (Btk) inhibitor that demonstrates …
Formula:
C27H29N5O3
Purity:
98.19%
Color and Shape:
Solid
Molecular weight:
471.55
Ref: TM-TQ0039
| 1mg | 49.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 150.00 € | ||
| 25mg | 265.00 € | ||
| 50mg | 423.00 € | ||
| 100mg | 606.00 € | ||
| 500mg | 1,253.00 € | ||
| 1mL*10mM (DMSO) | 104.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
c-Kit-IN-3
CAS:2363169-01-9
c-Kit-IN-3 is a selective inhibitor of c-KIT kinase with IC50s of 4 nM and 8 …
Formula:
C26H20ClF3N2O4
Purity:
99.43%
Color and Shape:
Solid
Molecular weight:
516.9
Ref: TM-T10651
| 1mg | 85.00 € | ||
| 5mg | 159.00 € | ||
| 10mg | 249.00 € | ||
| 25mg | 411.00 € | ||
| 50mg | 551.00 € | ||
| 100mg | 771.00 € | ||
| 500mg | 1,545.00 € | ||
| 1mL*10mM (DMSO) | 333.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
c-Fms-IN-1
CAS:885703-64-0
c-Fms-IN-1 is an inhibitor of c-FMS kinase (IC50 = 0.8 nM).
Formula:
C22H27N5O2
Purity:
99.88%
Color and Shape:
Solid
Molecular weight:
393.48
Ref: TM-T10643
| 2mg | 41.00 € | ||
| 5mg | 63.00 € | ||
| 10mg | 94.00 € | ||
| 25mg | 171.00 € | ||
| 50mg | 260.00 € | ||
| 100mg | 376.00 € | ||
| 1mL*10mM (DMSO) | 70.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ansornitinib
CAS:1448874-96-1
Ansornitinib (ANG-3070) is a KDR and PDGF receptor inhibitor with antifibrotic activity for the study …
Formula:
C30H32N6O4
Color and Shape:
Solid
Molecular weight:
540.61
Ref: TM-T63809
| 1mg | 138.00 € | ||
| 5mg | 295.00 € | ||
| 10mg | 462.00 € | ||
| 25mg | 993.00 € | ||
| 50mg | 1,568.00 € | ||
| 100mg | 2,319.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
FLT3-IN-4
CAS:2304799-09-3
FLT3-IN-4 (FLT3 inhibitor 9u) is a potent and orally effective Fms-like tyrosine receptor kinase 3 …
Formula:
C23H25N7O2
Purity:
98.96%
Color and Shape:
Solid
Molecular weight:
431.49
Ref: TM-T11299
| 1mg | 91.00 € | ||
| 5mg | 221.00 € | ||
| 10mg | 328.00 € | ||
| 25mg | 527.00 € | ||
| 50mg | 713.00 € | ||
| 100mg | 917.00 € | ||
| 500mg | 1,838.00 € | ||
| 1mL*10mM (DMSO) | 248.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
EGFR-IN-9
CAS:1226549-39-8
EGFR-IN-9 is a potent EGFR kinase inhibitor with IC50s of 7 nM, 28 nM for …
Formula:
C29H24N4O3
Purity:
99.46%
Color and Shape:
Solid
Molecular weight:
476.53
Ref: TM-T11163
| 1mg | 52.00 € | ||
| 5mg | 110.00 € | ||
| 10mg | 168.00 € | ||
| 25mg | 326.00 € | ||
| 50mg | 496.00 € | ||
| 1mL*10mM (DMSO) | 115.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
JTV-519 free base
CAS:145903-06-6
JTV-519 free base (K201 free base), recognized for its antiarrhythmic and cardioprotective properties, functions as …
Formula:
C25H32N2O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
424.6
Ref: TM-T11731
| 25mg | 1,410.00 € | ||
| 50mg | 1,845.00 € | ||
| 100mg | 2,329.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
FGFR2-IN-1
CAS:2677709-76-9
FGFR2-IN-1 is an FGFR inhibitor that inhibits FGFR1, FGFR2, and FGFR3, and can be used …
Formula:
C22H19N3O2
Purity:
98.71%
Color and Shape:
Liquid
Molecular weight:
357.41
Ref: TM-T61304
| 1mg | 60.00 € | ||
| 5mg | 130.00 € | ||
| 10mg | 198.00 € | ||
| 25mg | 333.00 € | ||
| 50mg | 495.00 € | ||
| 100mg | 704.00 € | ||
| 500mg | 1,419.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
(R)-Zanubrutinib
CAS:1691249-44-1
(R)-Zanubrutinib ((R)-BGB-3111) is a selective inhibitor of Bruton tyrosine kinase (BTK).
Formula:
C27H29N5O3
Purity:
98.04%
Color and Shape:
Solid
Molecular weight:
471.55
Ref: TM-T13447
| 1mg | 39.00 € | ||
| 5mg | 84.00 € | ||
| 10mg | 140.00 € | ||
| 25mg | 225.00 € | ||
| 50mg | 339.00 € | ||
| 100mg | 464.00 € | ||
| 200mg | 646.00 € | ||
| 1mL*10mM (DMSO) | 90.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
EGFR-IN-99
CAS:2068806-31-3
EGFR-IN-99 (JBJ-03-142-02) is an EGFR and HER2 Exon 20 insertion mutation inhibitor for the study …
Formula:
C25H22FN7O3
Purity:
97.75%
Color and Shape:
Liquid
Molecular weight:
487.49
Ref: TM-T35901
| 1mg | 125.00 € | ||
| 5mg | 297.00 € | ||
| 10mg | 441.00 € | ||
| 25mg | 714.00 € | ||
| 50mg | 979.00 € | ||
| 100mg | 1,324.00 € | ||
| 500mg | 2,639.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
SKLB 1028
CAS:1350544-93-2
SKLB 1028, an oral EGFR/FLT3/Abl inhibitor, excels in AML and CML with Abl mutations.
Formula:
C24H29N9
Purity:
99.71% - 99.85%
Color and Shape:
Solid
Molecular weight:
443.55
Ref: TM-T34656
| 1mg | 56.00 € | ||
| 5mg | 120.00 € | ||
| 10mg | 188.00 € | ||
| 25mg | 378.00 € | ||
| 50mg | 560.00 € | ||
| 100mg | 802.00 € | ||
| 200mg | 634.00 € | ||
| 500mg | 1,616.00 € | ||
| 1mL*10mM (DMSO) | 144.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Tafetinib
CAS:1032265-57-8
Tafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and …
Formula:
C24H29FN4O2
Purity:
96.66%
Color and Shape:
Solid
Molecular weight:
424.51
Ref: TM-T28911
| 1mg | 233.00 € | ||
| 5mg | 581.00 € | ||
| 10mg | 824.00 € | ||
| 25mg | 1,234.00 € | ||
| 50mg | 1,654.00 € | ||
| 100mg | 2,265.00 € | ||
| 500mg | 4,532.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Spebrutinib besylate
CAS:1360053-81-1
Spebrutinib besylate (AVL-292 benzenesulfonate; CC-292 besylate) is a Btk kinase activity inhibitor (IC50<0.5 nM, …
Formula:
C28H28FN5O6S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
581.62
Ref: TM-T14357
| 25mg | 1,410.00 € | ||
| 50mg | 1,851.00 € | ||
| 100mg | 2,337.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Paltimatrectinib
CAS:2353522-15-1
Paltimatrectinib (PBI-200) is a tyrosine kinase inhibitor with anticancer activity, and is used in the …
Formula:
C20H15F5N6
Purity:
99.96%
Color and Shape:
Solid
Molecular weight:
434.37
Ref: TM-T62447
| 1mg | 185.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
Zidesamtinib
CAS:2739829-00-4
Zidesamtinib (NVL-520) is a ROS1 fusion and resistance mutation inhibitor that inhibits ROS1 and can …
Formula:
C22H22FN7O
Purity:
99.78%
Color and Shape:
Solid
Molecular weight:
419.455
Ref: TM-T72953
| 1mg | 158.00 € | ||
| 5mg | 349.00 € | ||
| 10mg | 621.00 € | ||
| 25mg | 1,087.00 € | ||
| 50mg | 1,471.00 € | ||
| 100mg | 2,089.00 € | ||
| 200mg | 2,773.00 € | ||
| 1mL*10mM (DMSO) | 372.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
Ropsacitinib
CAS:2127109-84-4
Ropsacitinib (PF-06826647) is a selective TYK2 inhibitor, which binds to TYK2 catalytically active JH1 domain …
Formula:
C20H17N9
Purity:
99.85%
Color and Shape:
Solid
Molecular weight:
383.41
Ref: TM-T13237L
| 1mg | 226.00 € | ||
| 2mg | 339.00 € | ||
| 5mg | 481.00 € | ||
| 10mg | 696.00 € | ||
| 25mg | 1,077.00 € | ||
| 50mg | 1,458.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
DYRKs-IN-2
CAS:1386980-04-6
DYRKs-IN-2 has antitumor activity. DYRKs-IN-2 is a potent DYRKs inhibitor with IC50s of 30.6 nM …
Formula:
C32H38ClN9O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
632.16
Ref: TM-T11133
| 25mg | 1,967.00 € | ||
| 50mg | 2,592.00 € | ||
| 100mg | 3,450.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
